Publications by authors named "Matous Hrdinka"

Claim this Profile
N
Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential.
Jana Kotulová, Klára Baďurová, Zuzana Chyra, Sabina Ševčíková, Nikola Garbová, Matouš Hrdinka

Biomark Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 and BRCA2 as prognostic markers in oral squamous cell carcinoma: a minireview.
Dominika Gedeonová, Claretta Bianchi, Jan Štembírek, Matouš Hrdinka, Zuzana Chyra

Front Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation.
Dhwani Radhakrishnan, Jana Kotulová, Lucie Hofmanová, Anjana Anilkumar Sithara, Marcello Turi, Matouš Hrdinka

J Leukoc Biol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into the mechanism of CD34 cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.
Ondrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, David Zihala, Ludmila Muronova, Matous Hrdinka

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
Tomas Jelinek, Renata Bezdekova, David Zihala, Tereza Sevcikova, Anjana Anilkumar Sithara, Matous Hrdinka

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility.
Piotr Celichowski, Marcello Turi, Sandra Charvátová, Dhwani Radhakrishnan, Neda Feizi, Matouš Hrdinka

J Transl Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling.
Marcello Turi, Anjana Anilkumar Sithara, Lucie Hofmanová, David Žihala, Dhwani Radhakrishnan, Matouš Hrdinka

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma.
Alexander Vdovin, Tomas Jelinek, David Zihala, Tereza Sevcikova, Michal Durech, Matous Hrdinka

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.
Martina Zátopková, Tereza Ševčíková, Viola Fanfani, Zuzana Chyra, Lucie Říhová, Matouš Hrdinka

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment.
Benjamin Motais, Sandra Charvátová, Zuzana Walek, Matouš Hrdinka, Ryszard Smolarczyk

Cells· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
Zuzana Chyra, Tereza Sevcikova, Petr Vojta, Janka Puterova, Lucie Brozova, Matous Hrdinka

Haematologica· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loop.
Helena Draberova, Sarka Janusova, Daniela Knizkova, Tereza Semberova, Michaela Pribikova, Matous Hrdinka

EMBO J· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercellular Mitochondrial Transfer in the Tumor Microenvironment.
Hana Sahinbegovic, Tomas Jelinek, Matous Hrdinka, Juli R Bago, Marcello Turi

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers.
Benjamin Motais, Sandra Charvátová, Matouš Hrdinka, Michal Šimíček, Tomáš Jelínek

Cancers (Basel)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitor of apoptosis proteins in human health and disease.
Matous Hrdinka, Monica Yabal

Genes Immun· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Matous Hrdinka, Lisa Schlicher, Bing Dai, Daniel M Pinkas, Joshua C Bufton

EMBO J· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax: A new wave in hematooncology.
Jana Mihalyova, Tomas Jelinek, Katerina Growkova, Matous Hrdinka, Michal Simicek

Exp Hematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation.
Matous Hrdinka, Mads Gyrd-Hansen

Mol Cell· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA-mediated excitotoxicity.
Dana O Kravchick, Anna Karpova, Matous Hrdinka, Jeffrey Lopez-Rojas, Sanda Iacobas

EMBO J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.
Paul R Elliott, Derek Leske, Matous Hrdinka, Katrin Bagola, Berthe K Fiil

Mol Cell· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice.
Matous Hrdinka, Kritika Sudan, Sissy Just, Ales Drobek, Ondrej Stepanek

PLoS One· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling.
Matous Hrdinka, Berthe Katrine Fiil, Mattia Zucca, Derek Leske, Katrin Bagola

Cell Rep· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
Peter Canning, Qui Ruan, Tobias Schwerd, Matous Hrdinka, Jenny L Maki

Chem Biol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane microdomains in immunoreceptor signaling.
Vaclav Horejsi, Matous Hrdinka

FEBS Lett· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transmembrane region is responsible for targeting of adaptor protein LAX into "heavy rafts".
Matous Hrdinka, Pavel Otahal, Vaclav Horejsi

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis